Next update will be end of April 4c quarterly report.. Won't reflect US progress since 501k approval but will provide an insight into auzzoe sale an update on clinical trial which is specifically interesting to me!
ALT Price at posting:
2.0¢ Sentiment: Sell Disclosure: Held